Reperfusion time targets in STEMI
The question asks for the
door-to-needle time for fibrinolytic therapy when primary PCI cannot be performed within its own time window. The correct target is
30 minutes from hospital arrival. This is a core quality metric in acute coronary syndrome care and appears repeatedly on licensure examinations because it tests whether you can distinguish the separate time goals for ECG, fibrinolysis, and PCI.
The underlying rationale is that myocardial necrosis progresses as a
wavefront of ischemic cell death from the endocardium toward the epicardium after coronary occlusion.
The faster blood flow is restored, the more myocardium can be salvaged, the smaller the infarct size, and the lower the mortality. Fibrinolytic agents lyse the culprit thrombus pharmacologically, so their benefit is highly time-dependent. A
30-minute door-to-needle target reflects the maximum acceptable delay when fibrinolysis is the chosen reperfusion strategy.
The other options represent different steps in the STEMI pathway. A
10-minute target applies to obtaining and interpreting the
12-lead ECG after arrival, not to drug administration. A
90-minute target is the
door-to-balloon time for primary PCI. A
60-minute figure is not a standard reperfusion benchmark in this context.
| Time target | Intervention | Clinical meaning |
|---|
| 10 minutes | 12-lead ECG acquisition and interpretation | Rapid identification of STEMI; triggers the reperfusion pathway |
| 30 minutes | Fibrinolytic therapy (door-to-needle) | Reperfusion when primary PCI is unavailable or delayed |
| 90 minutes | Primary PCI (door-to-balloon) | Preferred reperfusion if a PCI-capable center is immediately accessible |
Key point! The
30-minute door-to-needle benchmark applies specifically to facilities where primary PCI cannot be achieved within
90 minutes. In such settings, fibrinolysis is often the only realistic reperfusion option, so nurses must recognize that the clock starts at hospital arrival and that every minute of delay reduces myocardial salvage.
Watch out! Do not confuse
door-to-needle with
door-to-balloon. The former is for fibrinolysis and has a shorter target because the drug can be prepared and administered more quickly than mobilizing a catheterization team. The latter is for PCI and allows
90 minutes because of the logistical complexity of the procedure.
The emphasis on rapid fibrinolysis is supported by evidence that timely lysis of the culprit clot restores perfusion, reduces infarct size, and saves lives. In practice, achieving the
30-minute target requires a coordinated response: immediate ECG, prompt recognition of STEMI, rapid screening for contraindications to fibrinolysis, and preparation of the thrombolytic agent without waiting for cardiac enzyme results.
The decision to give fibrinolysis is based on the ECG and clinical presentation, not on troponin levels, because biomarker elevation lags behind the ischemic injury.